- Home
- VRAX vs CHNR Comparison
VRAX vs CHNR Comparison
Compare VRAX & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- CHNR
- Stock Information
- Founded
- VRAX 2013
- CHNR N/A
- Country
- VRAX United Kingdom
- CHNR China
- Employees
- VRAX N/A
- CHNR N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CHNR Precious Metals
- Sector
- VRAX Health Care
- CHNR Basic Materials
- Exchange
- VRAX Nasdaq
- CHNR Nasdaq
- Market Cap
- VRAX 4.4M
- CHNR 4.6M
- IPO Year
- VRAX 2022
- CHNR 1995
- Fundamental
- Price
- VRAX $0.75
- CHNR $3.48
- Analyst Decision
- VRAX Strong Buy
- CHNR
- Analyst Count
- VRAX 1
- CHNR 0
- Target Price
- VRAX $3.00
- CHNR N/A
- AVG Volume (30 Days)
- VRAX 132.3K
- CHNR 77.0K
- Earning Date
- VRAX 01-01-0001
- CHNR 05-15-2025
- Dividend Yield
- VRAX N/A
- CHNR N/A
- EPS Growth
- VRAX N/A
- CHNR N/A
- EPS
- VRAX N/A
- CHNR N/A
- Revenue
- VRAX $6,331.00
- CHNR N/A
- Revenue This Year
- VRAX $217,274.83
- CHNR N/A
- Revenue Next Year
- VRAX N/A
- CHNR N/A
- P/E Ratio
- VRAX N/A
- CHNR N/A
- Revenue Growth
- VRAX N/A
- CHNR N/A
- 52 Week Low
- VRAX $0.72
- CHNR $3.16
- 52 Week High
- VRAX $9.00
- CHNR $9.04
- Technical
- Relative Strength Index (RSI)
- VRAX 38.90
- CHNR 45.08
- Support Level
- VRAX $0.72
- CHNR $3.36
- Resistance Level
- VRAX $0.80
- CHNR $3.83
- Average True Range (ATR)
- VRAX 0.07
- CHNR 0.32
- MACD
- VRAX -0.01
- CHNR 0.00
- Stochastic Oscillator
- VRAX 10.07
- CHNR 20.38
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.